52 related articles for article (PubMed ID: 38697818)
1. Metabolomic biomarkers in cervicovaginal fluid for detecting endometrial cancer through nuclear magnetic resonance spectroscopy.
Cheng SC; Chen K; Chiu CY; Lu KY; Lu HY; Chiang MH; Tsai CK; Lo CJ; Cheng ML; Chang TC; Lin G
Metabolomics; 2019 Oct; 15(11):146. PubMed ID: 31664624
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic prediction of endometrial cancer.
Bahado-Singh RO; Lugade A; Field J; Al-Wahab Z; Han B; Mandal R; Bjorndahl TC; Turkoglu O; Graham SF; Wishart D; Odunsi K
Metabolomics; 2017 Dec; 14(1):6. PubMed ID: 30830361
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics in endometrial cancer diagnosis: A systematic review.
Raffone A; Troisi J; Boccia D; Travaglino A; Capuano G; Insabato L; Mollo A; Guida M; Zullo F
Acta Obstet Gynecol Scand; 2020 Sep; 99(9):1135-1146. PubMed ID: 32180221
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Serum Metabolomic Signature for Endometrial Cancer Screening in Postmenopausal Women.
Troisi J; Raffone A; Travaglino A; Belli G; Belli C; Anand S; Giugliano L; Cavallo P; Scala G; Symes S; Richards S; Adair D; Fasano A; Bottigliero V; Guida M
JAMA Netw Open; 2020 Sep; 3(9):e2018327. PubMed ID: 32986110
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic Signature of Endometrial Cancer.
Troisi J; Sarno L; Landolfi A; Scala G; Martinelli P; Venturella R; Di Cello A; Zullo F; Guida M
J Proteome Res; 2018 Feb; 17(2):804-812. PubMed ID: 29235868
[TBL] [Abstract][Full Text] [Related]
6. Potential application of body fluids autofluorescence in the non-invasive diagnosis of endometrial cancer.
Švecová M; Fiedlerová K; Mareková M; Dubayová K
Klin Onkol; 2024; 38(2):102-109. PubMed ID: 38697818
[TBL] [Abstract][Full Text] [Related]
7. Minimally invasive approaches for the early detection of endometrial cancer.
Shen Y; Yang W; Liu J; Zhang Y
Mol Cancer; 2023 Mar; 22(1):53. PubMed ID: 36932368
[TBL] [Abstract][Full Text] [Related]
8. Novel approaches to early detection of endometrial cancer.
Bagaria M; Shields E; Bakkum-Gamez JN
Curr Opin Obstet Gynecol; 2017 Feb; 29(1):40-46. PubMed ID: 27861202
[TBL] [Abstract][Full Text] [Related]
9. Advances in endometrial cancer protein biomarkers for use in the clinic.
Martinez-Garcia E; Lopez-Gil C; Campoy I; Vallve J; Coll E; Cabrera S; Ramon Y Cajal S; Matias-Guiu X; Van Oostrum J; Reventos J; Gil-Moreno A; Colas E
Expert Rev Proteomics; 2018 Jan; 15(1):81-99. PubMed ID: 29183259
[TBL] [Abstract][Full Text] [Related]
10. New perspectives on screening and early detection of endometrial cancer.
Costas L; Frias-Gomez J; Guardiola M; Benavente Y; Pineda M; Pavón MÁ; Martínez JM; Climent M; Barahona M; Canet J; Paytubi S; Salinas M; Palomero L; Bianchi I; Reventós J; Capellà G; Diaz M; Vidal A; Piulats JM; Aytés Á; Ponce J; Brunet J; Bosch FX; Matias-Guiu X; Alemany L; de Sanjosé S;
Int J Cancer; 2019 Dec; 145(12):3194-3206. PubMed ID: 31199503
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics: a revolution for novel cancer marker identification.
Bu Q; Huang Y; Yan G; Cen X; Zhao YL
Comb Chem High Throughput Screen; 2012 Mar; 15(3):266-75. PubMed ID: 22221059
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
